Navigation Links
Alticor Enters Into Joint Venture Agreement With Metagenics

ADA, Mich. and SAN CLEMENTE, Calif., Aug. 11 /PRNewswire/ -- Alticor, a global company with an uncompromising commitment to innovative scientific research and development of quality products, and Metagenics, a premier manufacturer and distributor of science-based medical foods and nutraceuticals marketed to health care professionals, today announced that they have entered into a joint venture agreement.

Under the terms of the agreement, Alticor will obtain a substantial ownership interest in Metagenics, and the current Metagenics shareholders will continue to retain a significant interest in the company. The agreement is subject to customary closing conditions, including approval by Metagenics shareholders and antitrust clearance. The closing is expected to take place later this summer. Detailed terms of the agreement were not disclosed.

"Today is an extraordinary day for Metagenics and its employees and customers around the world as we join forces with a partner that shares our commitment to science-based nutrition and wellness," said Jeffrey J. Katke, Chairman and CEO of Metagenics. "Alticor is an $8 billion global company with an unwavering dedication to research and the development of best-in-class products. We are confident that this joint venture will give Metagenics new opportunities to expand and grow - allowing us to further enhance the innovative product offerings our trusted health care professionals have come to expect."

Katke added, "Metagenics remains dedicated to its values. We believe this joint venture, by giving us access to financial resources to support our internal growth and our acquisition strategy, will help Metagenics realize its vision of reversing the chronic illness epidemic. Metagenics will continue to operate as a stand-alone company, delivering medical foods and nutraceuticals through health care professionals around the world."

"Alticor and Metagenics share a philosophy for promoting good nutrition, healthy living and natural science," said Jim Weaver, Vice President - Alticor Corporate Enterprises. "Each company boasts a deep commitment to science and nature with leading research and development teams dedicated to harnessing the power of plant-based, natural, scientific research. This joint venture fits into our strategy to bring complementary brands into our family of businesses, and we are pleased to be partnering with Metagenics' world-class employees and management team."

Alticor and Metagenics each have a long history of dedication to health, wellness and the application of advanced science and technology.

Alticor, through its NUTRILITE(TM) brand, conducts innovative nutrition research and offers more than 200 products to address the individual nutritional and wellness needs of anyone at any life stage. Many of NUTRILITE's products are manufactured using botanicals grown either on NUTRILITE-owned certified organic farms or on farms that adhere to sustainable farming principles to ensure the best products are delivered to individuals seeking to maintain a healthy lifestyle.

Metagenics' investment in scientific research led to the development of its leading nutrigenomic research center. The center develops science-based medical foods and nutraceuticals for nutritional support of clinically tested therapeutic lifestyle-change programs. Therapeutic lifestyle change programs are emerging as the preferred method for the treatment and prevention of chronic illnesses.

In forming the joint venture, Bryan Cave provided legal counsel for Alticor and Crowe Horwath served as financial advisors. Canaccord Adams acted as exclusive financial adviser to Metagenics, and McDermott Will & Emery provided legal counsel.

About Alticor

Alticor ( is the parent company of Amway Corp., Amway Global, Access Business Group LLC and Alticor Corporate Enterprises. Headquartered in Ada, Michigan, USA, Alticor and its affiliates offer products, business opportunities, and product development, manufacturing and logistic services in more than 80 countries and territories worldwide. In its most recent financial year, the company reported worldwide sales of more than $8.2 billion. For further information, please contact Alticor's media information line at 616-787-7565 or e-mail Alticor's media relations staff at

    Ania Zdrada
    Corporate Communications

About Metagenics

Metagenics ( headquartered in San Clemente, CA, is a global life sciences company focused on reversing chronic illness and improving health. Founded in 1983, the company serves tens of thousands of health care professionals and more than a million patients throughout the world and holds more than 40 proprietary formula patents for use in nutraceuticals, medical foods, and pharmaceuticals. Today, Metagenics continues its leadership role through its world class sales force, by successfully merging the disciplines of nutritional genomics, functional medicine, and therapeutic lifestyle change programs to find solutions to society's most pressing health concerns.

    Joseline L. Davison
    Corporate Communications
    Metagenics, Inc.

SOURCE Alticor
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Alticors 2007 Global Sales Top $7 Billion
2. Photos: Lumixyl(TM) Enters the Market to Improve the Appearance of Hyperpigmentation without Irritation and Side Effects
3. Memorial Blood Centers Joins Extreme Makeover: Home Edition As Designated Charity
4. Millin Associates has the Perfect Solution for Hospitals & Health Centers Dealing With an Influx of Uninsured Patients
5. Great Expressions Dental Centers, Inc. Acquires Willow Creek Dental Care in Canton, MI
6. AHIMA Enters Multinational Arena to Support HIM Worldwide Advancement
7. Medicare Cuts Will Force Many Cancer Centers To Close, Stop Seeing Medicare Patients, Lay Off Staff, According To ASTRO Survey
8. Texas Kidney Community: CMS Authorization to Survey 22 New Dialysis Centers Excellent First Step Toward Opening Additional Pending Facilities, Creating More Local Jobs
9. SETO Holdings, Inc. Enters Into Two Additional Leases for Two New Hearing Centers in Maryland and Virginia
10. Assara Laser Hair Removal Centers (New York, NY) Receives 2008 New York Award for Cosmetology & Personal Hygiene Salons by the U.S.C.A.
11. NeoGenomics Enters into Strategic Supply Agreement with Abbott for Development of a Melanoma Cancer Test
Post Your Comments:
(Date:11/28/2015)... PITTSBURGH, PA (PRWEB) , ... November 28, 2015 , ... ... Manalapan, N.J., has created the COUCH BUDDY. "I conceived of this design due to ... more comfort for couch users. It promotes relaxation and convenience, as well as increases ...
(Date:11/27/2015)... CA (PRWEB) , ... November 27, 2015 , ... According ... carried out by the University of Toronto and the University of British Columbia suggested ... hospitalizations for head injuries. The article explains that part of the reason for the ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... the toilets were," said an inventor from Hillside, N.J. "Many people catch diseases ... cover so that individuals will always be protected from germs." , He developed ...
(Date:11/27/2015)... ... November 27, 2015 , ... ... progress through sharing, the 2016 Building Better Radiology Marketing Programs meeting ... begin on Sunday, March 6, 2016, at Caesars Palace in Las Vegas with ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... CBD ... Accreditation of Allied Health Education Programs (CAAHEP) awarded accreditation to its Diagnostic Medical Sonography ... CAAHEP accredited colleges, as only one of twelve colleges and universities in the state ...
Breaking Medicine News(10 mins):
(Date:11/27/2015)... PHILADELPHIA , Nov. 27, 2015  Lannett ... that it has completed the acquisition of Kremers ... pharmaceuticals subsidiary of global biopharmaceuticals company UCB S.A. ... --> Lannett has acquired KU from UCB ... to certain adjustments, including a customary working capital ...
(Date:11/26/2015)... India , November 27, ... --> --> ... personal emergency response system (PERS) ... steadily for 5 years with ... region expected to see a ...
(Date:11/26/2015)... --> --> ... immunotherapy with Bremachlorin-photodynamic therapy for advanced cancer.   ... with Bremachlorin-photodynamic therapy for advanced cancer.   ... with Bremachlorin-photodynamic therapy for advanced cancer.   ... immunotherapy can be efficiently combined with photodynamic therapy (PDT) ...
Breaking Medicine Technology: